HCP (NYSE: HCP) lowered its earnings expectations for its struggling senior health care assets in the U.K. The company will record an impairment charge of $42 million this quarter. HCP now projects funds from operations of $1.92 to $1.98 per unit, down from a prior estimate of $2.02 to $2.08 per share. Earnings are now expected to be $0.74 to $0.80 per share, down $0.84 to $0.90 previously.

This month, the company also closed on its previously announced acquisition of 35 private pay senior housing communities from Chartwell Retirement Residences for $847 million.

Yielding 6.1%, conservative holding HCP is a Buy up to $44.

Novartis (NYSE: NVS) is facing a $3.3 billion lawsuit filed by the U.S. government for thousands of fraudulent reimbursement claims to Medicare and Medicaid. The suit claims that the company paid kickbacks to increase sales of two of its prescription drugs, Exjade, which removes excess iron from patients’ blood, and Myfortic to prevent rejection of kidney transplants. Shares 2% fell immediately following the news. The case was tried in New York in November of this year.

Novartis remains a Buy below $100.

Banco Bradesco’s (NYSE: BBD) board of directors approved plans to buy up to 15 million shares (7.5 million preferred shares and 7.5 million common shares) over the next 12 months. At its current price the value of the buyback would total about $140 million.

Buy Banco Bradesco up to $14.

In an effort to contain the losses associated with its Chile business, Marine Harvest (NYSE: MHG) said it will cut its headcount and smolt (young salmon) stocking in Chile, reducing its smolt output from 17 million to 11 million which will affect future supplies.

Along with lower production costs the company will also reduce its number of employees. The company also recently detected a case of infectious salmon anemia on one of its farms

Yielding 9.3%, GIE’s #2 aggressive holding, MHG is a Buy up to $16.

Starwood Property Trust (NYSE: STWD) announced it will use its existing cash to extend its buyback program one year and $200 million. The company is now authorized to buy back up to $450 million of its outstanding shares until June 22, 2016. The buyback will be funded by its existing cash.

STWD is a Buy up to $32.